Blair William & Co. IL Has $1.30 Million Stake in Maximus, Inc. (MMS)
Blair William & Co. IL reduced its position in Maximus, Inc. (NYSE:MMS) by 4.8% during the second quarter, according to its most recent disclosure with the SEC. The institutional investor owned 20,695 shares of the health services provider’s stock after selling 1,036 shares during the period. Blair William & Co. IL’s holdings in Maximus were worth $1,296,000 as of its most recent SEC filing.
Other hedge funds also recently made changes to their positions in the company. Bank of Montreal Can boosted its stake in shares of Maximus by 56.5% in the first quarter. Bank of Montreal Can now owns 125,084 shares of the health services provider’s stock worth $7,780,000 after buying an additional 45,167 shares in the last quarter. Capstone Asset Management Co. boosted its stake in shares of Maximus by 3.0% in the first quarter. Capstone Asset Management Co. now owns 6,972 shares of the health services provider’s stock worth $434,000 after buying an additional 200 shares in the last quarter. Louisiana State Employees Retirement System boosted its stake in shares of Maximus by 2.5% in the first quarter. Louisiana State Employees Retirement System now owns 16,400 shares of the health services provider’s stock worth $1,020,000 after buying an additional 400 shares in the last quarter. Glen Harbor Capital Management LLC raised its position in Maximus by 1.9% in the first quarter. Glen Harbor Capital Management LLC now owns 2,332 shares of the health services provider’s stock worth $145,000 after buying an additional 44 shares during the last quarter. Finally, Shell Asset Management Co. acquired a new position in Maximus during the first quarter worth approximately $542,000. 97.22% of the stock is owned by institutional investors.
Maximus, Inc. (NYSE:MMS) opened at 59.36 on Monday. The stock has a 50 day moving average price of $60.48 and a 200-day moving average price of $61.15. The company has a market capitalization of $3.85 billion, a price-to-earnings ratio of 19.03 and a beta of 1.39. Maximus, Inc. has a 1-year low of $43.69 and a 1-year high of $64.97.
Maximus (NYSE:MMS) last released its quarterly earnings results on Thursday, August 3rd. The health services provider reported $0.79 earnings per share for the quarter, topping the consensus estimate of $0.76 by $0.03. Maximus had a net margin of 8.43% and a return on equity of 25.08%. The business had revenue of $600.40 million for the quarter, compared to analysts’ expectations of $614.12 million. During the same period in the previous year, the company earned $0.79 earnings per share. The firm’s revenue for the quarter was down 2.7% compared to the same quarter last year. Equities analysts predict that Maximus, Inc. will post $3.12 earnings per share for the current year.
The company also recently declared a quarterly dividend, which will be paid on Thursday, August 31st. Investors of record on Tuesday, August 15th will be issued a dividend of $0.045 per share. This represents a $0.18 annualized dividend and a yield of 0.30%. The ex-dividend date of this dividend is Friday, August 11th. Maximus’s dividend payout ratio (DPR) is presently 5.73%.
COPYRIGHT VIOLATION NOTICE: This news story was published by TheOlympiaReport and is the property of of TheOlympiaReport. If you are viewing this news story on another website, it was illegally copied and republished in violation of U.S. & international copyright & trademark laws. The original version of this news story can be read at https://theolympiareport.com/2017/08/28/blair-william-co-il-has-1-30-million-stake-in-maximus-inc-mms.html.
A number of research firms have recently commented on MMS. KeyCorp reiterated a “sector weight” rating on shares of Maximus in a research note on Thursday, May 25th. ValuEngine lowered Maximus from a “buy” rating to a “hold” rating in a research note on Tuesday, May 16th. Canaccord Genuity lowered Maximus from a “buy” rating to a “hold” rating and set a $62.00 price objective on the stock. in a research note on Tuesday, July 4th. BidaskClub lowered Maximus from a “strong-buy” rating to a “buy” rating in a research note on Thursday, July 6th. Finally, Zacks Investment Research upgraded Maximus from a “sell” rating to a “hold” rating in a research note on Wednesday, July 26th. One analyst has rated the stock with a sell rating and eight have given a hold rating to the stock. Maximus presently has an average rating of “Hold” and a consensus target price of $62.17.
In other Maximus news, CEO Richard A. Montoni sold 29,203 shares of the business’s stock in a transaction dated Thursday, August 17th. The shares were sold at an average price of $60.38, for a total value of $1,763,277.14. Following the transaction, the chief executive officer now directly owns 549,215 shares in the company, valued at $33,161,601.70. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, General Counsel David Francis sold 2,000 shares of the business’s stock in a transaction dated Friday, August 18th. The shares were sold at an average price of $58.89, for a total transaction of $117,780.00. Following the completion of the transaction, the general counsel now owns 13,716 shares in the company, valued at $807,735.24. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 118,342 shares of company stock worth $7,247,617. 3.10% of the stock is owned by corporate insiders.
Maximus Company Profile
MAXIMUS, Inc provides business process services (BPS) to government health and human services agencies. The Company operates through three segments: U.S. Federal Services, Health Services and Human Services. The U.S. Federal Services segment provides BPS and program management for large government programs, independent health review and appeals services for both the United States Federal Government, and state-based programs and technology solutions for civilian federal programs.
Want to see what other hedge funds are holding MMS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Maximus, Inc. (NYSE:MMS).
Receive News & Ratings for Maximus Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.